Searching Case Laws & Precedent on Legal Query.....!
Scanned Judgements…!
Searching Case Laws & Precedent on Legal Query.....!
Scanned Judgements…!
Protection under Section 19(3) of the Drugs and Cosmetics Act, 1940 - A distributor who unknowingly acquires drugs from a licensed manufacturer and stores them properly may be protected from liability under Section 19(3), which states that if the drug remains in the same state and was properly stored, the person in possession is not liable for contravention of certain provisions ["2025 Supreme(Online)(PH) 1634"]. This protection applies if the distributor can demonstrate that they acquired the drugs from a licensed source and maintained them properly.
Unintentional or Unknowingly Doing the Same - When a distributor is unaware of the contravention (e.g., drugs not meeting standards or misbranding), the key legal safeguard is the requirement to prove that they did not intentionally violate the law. Section 19(3) provides a defense if the distributor can show they obtained the drugs from a licensed manufacturer and maintained proper storage, thus not being liable for offences under Sections 18 and 27 ["2024 0 Supreme(AP) 724"], ["2024 Supreme(Online)(MAD) 442"].
Strict Liability and Distribution - The law considers distribution a strict liability offence, meaning even free distribution can violate Section 18(c) unless exemptions apply. However, Rule 123 of the Drugs and Cosmetics Rules, 1945, exempts certain drugs from licensing requirements if specified in Schedule K, which may offer some protection in cases of free distribution under specific conditions ["2025 Supreme(Online)(Del) 8495"].
Distributors’ Responsibility and Legal Safeguards - The courts recognize that distributors or marketing agents are not responsible for branding or manufacturing details, and if they can prove they acted in good faith and obtained drugs from licensed manufacturers, they can avoid liability. For example, mere misbranding on labels does not automatically implicate distributors if they were unaware or had no role in the misbranding ["2024 Supreme(Online)(KER) 45840"].
Legal Recourse and Defenses - Distributors can invoke provisions like Section 19(3) and demonstrate proper procurement and storage to defend against prosecutions. Courts have consistently held that if the conditions of lawful possession are met, the distributor is protected from liability, even if the drugs later turn out to be substandard or misbranded ["2023 0 Supreme(Del) 3777"], ["2024 Supreme(Online)(MAD) 442"].
Analysis and Conclusion:A distributor can be absolved from liability under the Drugs and Cosmetics Act when they unknowingly do the same by establishing that they acquired the drugs from a licensed manufacturer, stored them properly, and had no knowledge of any contravention. The key legal shield is Section 19(3), which protects persons in possession of drugs in the same state they received them, provided they can prove proper procurement and storage. Therefore, even if the distributor was unaware of violations, they may avoid penal consequences if they fulfill these conditions and can substantiate their good faith and compliance with licensing requirements ["2025 Supreme(Online)(PH) 1634"], ["2024 0 Supreme(AP) 724"].
In the pharmaceutical and cosmetics distribution business, handling products that unknowingly violate regulations can expose distributors to serious legal risks. But what if a distributor has no knowledge of the contravention? The question arises: How can a distributor be free from the Drugs and Cosmetics Act when he unknowingly does the same?
This blog explores the legal defenses available, emphasizing and . Drawing from judicial interpretations and statutory principles, we'll outline pathways to exemption from liability. Note: This is general information based on legal precedents and not specific legal advice—consult a qualified lawyer for your situation.
Under the (the Act), a distributor can be considered free from liability when unknowingly dealing with drugs or cosmetics that contravene the Act, provided he discharges his statutory obligation of and does not have knowledge or reasonable means to ascertain the contravention1999 0 Supreme(Raj) 712.
The Act does not impose ; it hinges on the distributor's mental state and conduct. Courts have consistently held that mere involvement in distribution does not trigger prosecution if is demonstrated. This aligns with broader principles of criminal law, where culpable intent or negligence is required.
Distributors operate in a chain where manufacturers and suppliers bear primary responsibility, but handlers must verify compliance. The legal framework recognizes that a distributor may unknowingly handle drugs or cosmetics in contravention, but exemption lies in exercising . Courts stress that a person who, in , conducts reasonable checks and inquiries, and has no actual or of contravention, cannot be held criminally liable 1999 0 Supreme(Raj) 712.
This principle ensures fairness under , preventing punishment without (guilty mind).
Judicial precedents reinforce that liability is not automatic without knowledge. For instance, in cases involving sample testing and prosecution, courts have quashed proceedings where procedural lapses or lack of direct involvement absolved parties. In one ruling, a former director was absolved due to resignation from the company and non-compliance with statutory provisions by inspectors: Non-compliance with statutory provisions and resignation of the accused from the company absolved him of liability, leading to the quashing of the proceedings 2024 0 Supreme(All) 597.
Similarly, proceedings were quashed when prosecutors lacked authority under : Prosecution under the can only be maintained if instituted by an Inspector, the person aggrieved, or a recognized consumer association 2012 0 Supreme(Jhk) 1423 2012 0 Supreme(Jhk) 1417. These cases highlight that without proper foundation—such as proven knowledge or negligence—distributors cannot be held liable.
In another context, failure to follow regarding sample dispatch to manufacturers led courts to scrutinize prosecutions closely, emphasizing procedural due process: The court found no obligation on the inspector to send a sample to the manufacturer as the retailer disclosed only the distributor’s details 2023 0 Supreme(P&H) 2640. This underscores that distributors' defenses strengthen when upstream compliance is verifiable.
The Act's provisions, like Sections 18, 27, and 34, focus on those with knowledge or control. Liability under the Act is not absolute and depends significantly on the mental element—knowledge or negligence. For instance, the court held that if the distributor had no knowledge of the contravention and had exercised reasonable care, he cannot be prosecuted or held liable 1999 0 Supreme(Raj) 712.
Cases involving companies further clarify: Under (Offences by companies), only those responsible at the time face liability. A director not involved in day-to-day operations escaped summons: The petitioners were not liable under as they were not responsible for the day-to-day operations of the company at the time of the alleged offense 2023 0 Supreme(Del) 3807.
While strong, the defense is not blanket:- Actual Knowledge or Negligence: If a distributor suspects issues but fails to investigate, liability attaches.- Failure to Verify: Mere suspicion without diligence negates exemption 1999 0 Supreme(Raj) 712.- Case-Specific Facts: Protection depends on evidence of ; courts assess each scenario individually 2024 0 Supreme(All) 597.
For example, possession without licensing is a contravention justifying seizure, but trial determines intent: Possession of drugs without proper licensing constitutes a contravention of the Drugs and Cosmetics Act, justifying seizure and requiring trial for legality 2024 0 Supreme(Guj) 2168. Distributors must prove diligence at trial.
To fortify defenses:- Maintain Records: Document supplier licenses, batch details, and compliance checks.- Implement Procedures: Verify labels, licensing (e.g., Form 21), and standards per Drugs and Cosmetics Rules 1974 0 Supreme(SC) 27.- Seek Advice: Consult legal experts on doubtful products; conduct audits.- Training: Educate staff on red flags like ( linked to Act) 2012 0 Supreme(Jhk) 1423.
In interconnected laws like , compliance with Drugs Rules is critical: Any person selling without abiding the Drugs and Cosmetics Rules, he will be liable to be punished under the 2022 0 Supreme(Mad) 848.
Distributors can navigate the Drugs and Cosmetics Act by prioritizing and , turning potential liability into a robust defense. Courts protect those without knowledge who act responsibly, as seen in quashed proceedings for procedural flaws or lack of involvement 2023 0 Supreme(P&H) 2640 2023 0 Supreme(Del) 3807.
Key Takeaways:- Exercise reasonable care to avoid .- No prosecution without proven or negligence.- Document everything—it's your shield.
Disclaimer: This article provides general insights from legal documents and cases like 1999 0 Supreme(Raj) 712, , 1974 0 Supreme(SC) 27, 2024 0 Supreme(All) 597, and others. Laws evolve, and outcomes vary by facts. Always seek professional legal counsel for personalized advice.
Stay compliant, distribute responsibly.
#DrugsCosmeticsAct, #DistributorLiability, #DueDiligenceLaw
Drugs and Cosmetics Act, 1940 . This provision reads as under: '27. ... However, all the petitioners have claimed protection under Section 19(3) of the Act. Section 19 of the Drugs and Cosmetics Act, 1940 read as under: Drugs and Cosmetics Act, 1940 [hereinafter referred as 'the Act'] and Rules made thereunder, against as many as ten accused as named below: Manufacturer: 1) M/s Burnent Pharma 9....
and Cosmetics Act, 1940 (for short “the Act”). ... Akums Drugs and Pharmaceuticals Limited (accused No.1) along with other drugs by following Section 23 of Drugs and Cosmetics Act, 1940 from M/s Medical Stores, East Coast Railway Divisional Hospital, Dondaparthy, Visakhapatnam. ... are responsible for the day-to-day affairs of the company, and accused Nos.4 to 6, who are the distributors of the drug, for the offences punishable under Section 18 (a) (....
It is imperative to underscore that the Drugs and Cosmetics Act, 1940, being public welfare legislation aims to regulate the import, manufacture, distribution, and sale of drugs and cosmetics. ... The Respondent contends that Section 18(c) of the Drugs and Cosmetics Act (DCA) is a “strict liability” offence where the motive is irrelevant, and that the distinct use of the words “sale” and “distribute” implies that even free distribut....
Section 23 (4)(iii) of the Drugs Cosmetics Act, 1940 (for short, 'the Act') and due to non-compliance of this provision, the petitioner - manufacturer could not get the same analysed and raise demand to adduce evidence in contravention of the report as provided under a href="./.. ... Section 23 (4)(iii) of Drugs and Cosmetic Act, 1940. Section 25 of the Act. It is urged that details of manufacturer were available with the Drugs Inspector as evident....
Rules 69A and 79 of the Drugs and Cosmetics Rules, 1945 6.3. ... and Cosmetics Act, 1940 (hereinafter referred to as `the Act`) and summoned the accused persons including the petitioners herein. ... Red) manufactured by Rose Chem, haying a license under the provisions of Drugs and Cosmetics Act, 1940 (briefly the Act; was found to be of non-standard quality in the report dated September 28, 1988, by the Government Analyst, Punjab. ....
He further relies on Section 34 of Drugs and Cosmetics Act. For ready reference Section 34 of Drugs and Cosmetics Act is quoted hereunder:- “Section 34 Offences by companies. ... Facts of the case are that a complaint under Section 32 of the Drugs and Cosmetics Act, 1940 (for short "Drugs and Cosmetics Act") was filed in the Court of Chief Judicial Magistrate, Muzaffar Nagar on 2....
and Cosmetics Act, 1940. ... and Cosmetics Act, 1940. ... So, as per Sec.19(3) of Drugs and Cosmetics Act, 1940, it requires that if a person pleads that he is not involved in contravention of Sec.18 of Drugs and Cosmetics Act, 1940, he must prove that he acquired from a duly ... The learned counsel for petitioner would submit that as a retailer, the petitioner borrowed the alleged drugs from A3,....
I have considered the relevant provisions of the Drugs and Cosmetics act and Rules. ... The provision of Section 31 of Drugs and Cosmetics Act are as under: "31. ... From the scheme of the Act, it transpires that if any accused is punished for the contravention of the Drugs and Cosmetics Act, then the goods are required to be confiscated. ... Considering the aforesaid fact, it prima facie, appears that, if any accu....
Non-compliance with the guidelines under the Drugs and Cosmetics (Amendment) Act, 2008 5. ... Rules 69A and 79 of the Drugs and Cosmetics Rules, 1945 6.3. ... and Cosmetics Act, 1940 (hereinafter referred to as 'the Act`) and summoned the accused persons including the petitioners herein. ... Red) manufactured by Rose Chem, haying a license under the provisions of Drugs and Cosmetics Act, 1940 (b....
At the outset it is essential to note the objectives of the two legislation before us, i.e., the Drugs and Cosmetics Act, 1940 and the N.D.P.S Act. The Drugs and Cosmetics Act, 1940 was enacted to specifically prevent sub−standard drugs and to maintain high standards of medical treatment. ... State of Maharashtra AIR 1963 SC 665) The Drugs and Cosmetics Act,1940 was mainly intended to curtail the ....
That apart, he obtained license under Form 21 and as such he was not licensed to sell the drugs mentioned in Schedule H1 of the Drugs and Cosmetics Rules. Therefore, the Section 80 of NDPS Act, Rule 65A of the NDPS Rules and Rule 65 of the Drugs and Cosmetics Act have to be read together. It can be understood that any person selling psychotropic substances without abiding the Drugs and Cosmetics Rules, he will be liable to be punished under the NDPS Act. Merely, because A7 claims to have the license or has a degree in Pharma education, it does not act as a safeguard for pro....
Here in the instant case, admittedly the prosecution, has never been launched either by Inspector or by the aggrieved person, rather it has launched by the Additional Deputy Commissioner, West Singhbhum, Chaibasa, upon which the matter was taken for investigation and the charge sheet was submitted upon which the cognizance of the offence has been taken and hence, order taking cognizance is certainly bad. Thus, there remain no doubt that the prosecution can be maintained under the Drugs and Cosmetics Act, 1940 only when the person, who, is competent under the aforesaid provision, la....
Thus, there remain no doubt that the prosecution can be maintained under the Drugs and Cosmetics Act, 1940 only when the person, who, is competent under the aforesaid provision, launches a prosecution under the Drugs and Cosmetics Act, 1940.
It has also been stated that Dettol even in common parlance is bought and sold as a drug and it is well known fact that Dettol kills germs and prevents illness and it is squarely covered by definition of drug, as per section 3(b) of the Drugs and Cosmetics Act, 1940 and it cannot be treated as a cosmetic or toilet preparation for the purpose of bringing under the Explanation of entry 21 of the Fourth Schedule. In fact, Dettol can be sold only under a licence under the Drugs and Cosmetics Act, 1940 and the petitioner had obtained a licence from the authority for dealing with Dettol ....
An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers
Please visit our Training & Support
Center or Contact Us for assistance
Scan Me!
India’s Legal research and Law Firm App, Download now!
For Daily Legal Updates, Join us on :
Back to top
